Germany's BioNTech has teamed up with Gilead Sciences to test its experimental cancer therapy in combination with the US ...

Advanced Clinical which is providing full-service clinical development, functional service provider (FSP) solutions and ...

Senior vice president tells The Pharma Letter how the US biotech major challenged the big pharma playbook, pairing a central ...

Boston, USA-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, ...

Georgiamune, the US clinical-stage immunology biotech, has granted Stemline Therapeutics, the oncology subsidiary of Italy’s ...

Privately-held German pharma company Boehringer Ingelheim and Microsoft have announced a strategic collaboration to ...

Japan’s Shionogi and UK-based F2G Ltd today announced results from the global Phase III OASIS study, in a late-breaking oral ...

INmune Bio Inc, a late-stage biotechnology company focused on inflammation and immunology, today announced that it has ...

Pharma major Roche reported third-quarter 2026 group sales of 16.13 billion Swiss francs ($19.61 billion), up 7% at constant ...

South Korea’s Samsung Bioepis today released its fourth quarter 2026 Market report, marking the fifteenth edition of the review on developments in the USA.

Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult patients with ...

Florida, USA-based biotech GOA Therapeutics has launched offerings totaling $300 million to fund the advancement of its drug ...